An Australian stem cell and regenerative medicine company
July 24, 2023
Dr Boreham’s Crucible
Following the change in leadership from Dr Ross Macdonald to Dr Kilian Kelly, Stockhead’s Tim Boreham examined Cynata in detail (though a mere days before the strategic review)